Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Physiology of the endometrium and regulation of menstruation. Physiol Rev. 2020;100:1149–79. https://doi.org/10.1152/physrev.00031.2019.

Article  PubMed  Google Scholar 

Su R-W, Fazleabas AT. Implantation and establishment of pregnancy in human and nonhuman primates. Adv Anat Embryol Cell Biol. 2015;216:189–213. https://doi.org/10.1007/978-3-319-15856-3_10.

Article  PubMed  PubMed Central  Google Scholar 

Fazleabas AT, Strakova Z. Endometrial function: cell specific changes in the uterine environment. Mol Cell Endocrinol. 2002;186:143–7. https://doi.org/10.1016/s0303-7207(01)00655-4.

Article  CAS  PubMed  Google Scholar 

Bińkowska M, Woroń J. Progestogens in menopausal hormone therapy. Prz Menopauzalny. 2015;14:134–43. https://doi.org/10.5114/pm.2015.52154.

Article  PubMed  PubMed Central  Google Scholar 

Agarwal N, Subramanian A. Endometriosis – morphology, clinical presentations and molecular pathology. J Lab Physicians. 2010;2:1–9. https://doi.org/10.4103/0974-2727.66699.

Article  PubMed  PubMed Central  Google Scholar 

Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: Pathogenesis, sequelae and treatment. SAGE Open Med. 2019;7:2050312119848247. https://doi.org/10.1177/2050312119848247.

Article  PubMed  PubMed Central  Google Scholar 

Ring KL, Mills AM, Modesitt SC. Endometrial hyperplasia. Obstet Gynecol. 2022;140:1061–75. https://doi.org/10.1097/AOG.0000000000004989.

Article  CAS  PubMed  Google Scholar 

Lentjes MHFM, Niessen HEC, Akiyama Y, de Bruïne AP, Melotte V, van Engeland M. The emerging role of GATA transcription factors in development and disease. Expert Rev Mol Med. 2016;18: e3. https://doi.org/10.1017/erm.2016.2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leubolt G, Redondo Monte E, Greif PA. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies. IUBMB Life. 2020;72:151–8. https://doi.org/10.1002/iub.2204.

Article  CAS  PubMed  Google Scholar 

Tsai F-Y, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371:221–6. https://doi.org/10.1038/371221a0.

Article  CAS  PubMed  Google Scholar 

Novakova M, Aliova M, Sukova M, Wlodarski M, Janda A, Froňková E, et al. Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome. Haematologica. 2016;101:707–16. https://doi.org/10.3324/haematol.2015.137711.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wlodarski MW, Hirabayashi S, Pastor V, Starý J, Hasle H, Masetti R, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127:1387–97. https://doi.org/10.1182/blood-2015-09-669937.

Article  CAS  PubMed  Google Scholar 

Hahn CN, Chong C-E, Carmichael CL, Wilkins EJ, Brautigan PJ, Li X-C, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43:1012–7. https://doi.org/10.1038/ng.913.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubel C, Jeong J-W, Tsai S, Lydon J, DeMayo F. Epithelial-stromal interaction and progesterone receptors in the mouse uterus. Semin Reprod Med. 2010;28:027–35. https://doi.org/10.1055/s-0029-1242990.

Article  CAS  Google Scholar 

Rubel CA, Franco HL, Jeong J-W, Lydon JP, DeMayo FJ. GATA2 is expressed at critical times in the mouse uterus during pregnancy. Gene Expr Patterns. 2012;12:196–203. https://doi.org/10.1016/j.gep.2012.03.004.

Article  CAS  PubMed  Google Scholar 

Rubel CA, Wu S-P, Lin L, Wang T, Lanz RB, Li X, et al. A Gata2-dependent transcription network regulates uterine progesterone responsiveness and endometrial function. Cell Rep. 2016;17:1414–25. https://doi.org/10.1016/j.celrep.2016.09.093.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song SH, Jeon MS, Nam JW, Kang JK, Lee YJ, Kang JY, et al. Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer. Oncogene. 2018;37:993–1004. https://doi.org/10.1038/onc.2017.397.

Article  CAS  PubMed  Google Scholar 

Pavlovic ZJ, Hsin-Yu Pai A, Hsiao T-T, Yen C-F, Alhasan H, Ozmen A, et al. Dysregulated expression of GATA2 and GATA6 transcription factors in adenomyosis: implications for impaired endometrial receptivity. F S Sci. 2024;5:92–103. https://doi.org/10.1016/j.xfss.2023.11.003.

Article  PubMed  Google Scholar 

Bresnick EH, Lee H-Y, Fujiwara T, Johnson KD, Keles S. GATA switches as developmental drivers. J Biol Chem. 2010;285:31087–93. https://doi.org/10.1074/jbc.R110.159079.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robbins DJ, Pavletich TS, Patil AT, Pahopos DC, Lasarev M, Polaki US, et al. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia. Blood Adv. 2023;8(1):80–92. https://doi.org/10.1182/bloodadvances.2023011554.

Article  CAS  PubMed Central  Google Scholar 

Dyson MT, Roqueiro D, Monsivais D, Ercan CM, Pavone ME, Brooks DC, et al. Genome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis. PLoS Genet. 2014;10:e1004158. https://doi.org/10.1371/journal.pgen.1004158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajagopalan A, Feng Y, Gayatri MB, Ranheim EA, Klungness T, Matson DR, et al. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice. J Clin Invest 2023;133(24). https://doi.org/10.1172/JCI173116.

Oulès B, Rognoni E, Hoste E, Goss G, Fiehler R, Natsuga K, et al. Mutant Lef1 controls Gata6 in sebaceous gland development and cancer. EMBO J 2019;38:e100526. https://doi.org/10.15252/embj.2018100526.

Oulès B, Deschamps L, Sohier P, Tihy M, Chassac A, Couvelard A, et al. Diagnostic accuracy of GATA6 immunostaining in sebaceous tumors of the skin. Mod Pathol. 2023;36:100101. https://doi.org/10.1016/j.modpat.2023.100101.

Article  PubMed  Google Scholar 

Machino H, Dozen A, Konaka M, Komatsu M, Nakamura K, Ikawa N, et al. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas. Exp Mol Med. 2023;55:2205–19. https://doi.org/10.1038/s12276-023-01090-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. 2014.

Ørbo A, Arnes M, Hancke C, Vereide AB, Pettersen I, Larsen K. Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only. Gynecol Oncol. 2008;111:68–73. https://doi.org/10.1016/j.ygyno.2008.06.014.

Article  PubMed  Google Scholar 

Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol. 2004;95:133–8. https://doi.org/10.1016/j.ygyno.2004.06.045.

Article  CAS  PubMed  Google Scholar 

Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol. 1997;90:434–40. https://doi.org/10.1016/s0029-7844(97)00297-4.

Article  CAS  PubMed  Google Scholar 

Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol. 2007;25:2798–803. https://doi.org/10.1200/JCO.2006.08.8344.

Article  CAS